心血管撮影デバイスの世界市場：心血管撮影装置、カテーテル・チューブ、ガイドワイヤー、バルーン、造影剤、血管閉塞デバイス...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY & PRICING 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 22
2.1.2.3 Break down of primary interviews 22
2.2 MARKET SIZE ESTIMATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4 MARKET SHARE ESTIMATION 25
2.5 ASSUMPTIONS FOR THE STUDY 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 GROWTH POTENTIAL OF THE ANGIOGRAPHY DEVICES MARKET 30
4.2 ANGIOGRAPHY END USER MARKET IN THE ASIA-PACIFIC REGION 31
4.3 ANGIOGRAPHY DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES 32
4.4 GEOGRAPHIC MIX: ANGIOGRAPHY DEVICES MARKET, BY PRODUCT 33
4.5 ANGIOGRAPHY DEVICES MARKET, BY END USER 34
4.6 ANGIOGRAPHY DEVICES MARKET, BY APPLICATION & REGION 34
4.7 ANGIOGRAPHY DEICES MARKET, BY PROCEDURES 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.2.1 BY TECHNOLOGY 37
5.2.2 BY PRODUCT 38
5.2.3 BY APPLICATION 39
5.2.4 BY PROCEDURE 39
5.2.5 BY INDICATION 40
5.2.6 BY END USER 40
5.3 MARKET DYNAMICS 41
5.3.1 KEY MARKET DRIVERS 42
5.3.1.1 Aging population and growing prevalence of cardiovascular diseases 42
5.3.1.2 Government investments 43
5.3.1.3 Awareness programs and conferences 43
5.3.1.4 FDA approval for angiography devices 44
5.3.1.5 Technological advancements 45
5.3.2 KEY MARKET RESTRAINTS 46
5.3.2.1 Lack of reimbursement or decreasing reimbursement for angiography procedures 46
5.3.2.2 Risk of radiation exposure in cath labs to curb usage of angiography devices 47
5.3.3 KEY MARKET OPPORTUNITIES 47
5.3.3.1 Growing investment potential in the emerging markets 47
5.3.4 MARKET CHALLENGES 48
5.3.4.1 High cost of angiography systems 49

6 INDUSTRY INSIGHTS 50
6.1 INTRODUCTION 50
6.2 INDUSTRY TRENDS 50
6.2.1 RISING TREND TOWARDS REDUCING RADIATION DOSES 50
6.3 PORTER’S FIVE FORCES ANALYSIS 51
6.3.1 THREAT OF NEW ENTRANTS 51
6.3.2 THREAT OF SUBSTITUTES 52
6.3.3 BARGAINING POWER OF SUPPLIERS 52
6.3.4 BARGAINING POWER OF BUYERS 52
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 53
6.4 STRATEGIC BENCHMARKING 53
6.4.1 KEY PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS A KEY STRATEGY TO INCREASE THEIR MARKET SHARES 53

7 ANGIOGRAPHY DEVICES MARKET, BY PRODUCT 55
7.1 INTRODUCTION 56
7.2 ANGIOGRAPHY SYSTEMS 57
7.3 CATHETER TUBES 58
7.4 GUIDEWIRES 59
7.5 BALLOONS 61
7.6 CONTRAST MEDIA 62
7.7 VASCULAR CLOSURE DEVICES 63
7.8 OTHER PRODUCTS & ACCESSORIES 64

8 ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY 65
8.1 INTRODUCTION 66
8.2 X-RAY ANGIOGRAPHY SYSTEMS 67
8.2.1 IMAGE INTENSIFIERS 69
8.2.2 FLAT-PANEL DETECTORS 70
8.3 CT ANGIOGRAPHY SYSTEMS 71
8.4 MRI ANGIOGRAPHY SYSTEMS 72

9 ANGIOGRAPHY DEVICES MARKET, BY APPLICATION 74
9.1 INTRODUCTION 75
9.2 DIAGNOSTIC APPLICATIONS 75
9.3 THERAPEUTIC APPLICATIONS 76

10 ANGIOGRAPHY DEVICES MARKET, BY PROCEDURE 78
10.1 INTRODUCTION 79
10.2 CORONARY ANGIOGRAPHY 80
10.3 MICROANGIOGRAPHY 82
10.4 NONCORONARY ANGIOGRAPHY 83
10.4.1 NEUROVASCULAR ANGIOGRAPHY 84
10.4.2 PERIPHERAL VASCULAR ANGIOGRAPHY 85
10.5 OTHER PROCEDURES 87

11 CORONARY ANGIOGRAPHY DEVICES MARKET, BY INDICATION 88
11.1 INTRODUCTION 89
11.2 KNOWN/SUSPECTED CAD 90
11.3 VALVULAR HEART DISEASE 92
11.4 CONGENITAL HEART DISEASE 93
11.5 CONGESTIVE HEART DISEASE 94
11.6 OTHER INDICATIONS 95

12 ANGIOGRAPHY DEVICES MARKET, BY END USER 96
12.1 INTRODUCTION 97
12.2 HOSPITALS 98
12.3 DIAGNOSTIC CENTERS 99
12.4 ACADEMIC RESEARCH LABORATORIES 100

13 GLOBAL ANGIOGRAPHY DEVICES MARKET, BY REGION 101
13.1 INTRODUCTION 102
13.2 NORTH AMERICA 103
13.2.1 U.S. 105
13.2.2 CANADA 107
13.3 EUROPE 109
13.3.1 GERMANY 112
13.3.2 FRANCE 114
13.3.3 U.K. 116
13.3.4 SPAIN 118
13.3.5 ITALY 119
13.3.6 REST OF EUROPE (ROE) 121
13.4 ASIA-PACIFIC 123
13.4.1 JAPAN 125
13.4.2 CHINA 127
13.4.3 INDIA 129
13.4.4 REST OF ASIA-PACIFIC (ROAPAC) 131
13.5 REST OF THE WORLD (ROW) 133
13.5.1 LATIN AMERICA 135
13.5.2 MIDDLE EAST AND AFRICA 137

14 COMPETITIVE LANDSCAPE 139
14.1 OVERVIEW 139
14.2 MARKET SHARE ANALYSIS: GLOBAL ANGIOGRAPHY SYSTEMS MARKET (2013) 140
14.3 KEY STRATEGIES ADOPTED BY LEADING PLAYERS 141
14.4 NEW PRODUCT LAUNCHES 143
14.5 MERGERS AND ACQUISITIONS 144
14.6 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS 145
14.7 EXPANSIONS 146

15 COMPANY PROFILES 147
(Overview, Financials, Products & Services, Strategy, & Developments)*
15.1 SIEMENS HEALTHCARE 148
15.2 GE HEALTHCARE (DIVISION OF GENERAL ELECTRIC CO.) 152
15.3 TOSHIBA MEDICAL SYSTEMS CORPORATION 155
15.4 PHILIPS HEALTHCARE 158
15.5 SHIMADZU CORPORATION 161
15.6 ST. JUDE MEDICAL, INC. 164
15.7 CORDIS CORPORATION (SUBSIDIARY OF JOHNSON AND JOHNSON) 167
15.8 ABBOTT VASCULAR INC. 169
15.9 BOSTON SCIENTIFIC CORPORATION 172
15.10 MEDTRONIC INC. 177
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

16 APPENDIX 180
16.1 INSIGHTS OF INDUSTRY EXPERTS 180
16.2 OTHER DEVELOPMENTS 181
16.3 DISCUSSION GUIDE 185
16.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 189
16.5 AVAILABLE CUSTOMIZATIONS 191
16.6 RELATED REPORTS 191